医疗保险优势索赔的验证,以评估低风险大动脉置换的长期结果
Christina Lalani1,2, Frank Medina2, Andrew S Oseran1,2
1Division of Cardiology (C.L., A.S.O., D.S.K., J.B.S., R.K.W., R.W.Y.), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Circulation. Cardiovascular quality and outcomes
|March 29, 2025
概括
医疗保险优势 (MA) 索赔与医疗保险服务费 (FFS) 索赔的准确性相似,用于评估大动脉置换后患者的并发症和结果. 这证实了MA对批准后研究的索赔,因为患者招募转移.
科学领域:
- 心血管医学 心血管医学
- 医疗保健服务研究 医疗服务研究
- 医疗信息学 医疗信息学
背景情况:
- 医疗保险优势 (MA) 计划覆盖超过50%的医疗保险受益人.
- 对于临床结果评估而言,授权申请数据的实用性,类似于医疗保险费用服务 (FFS),尚未得到充分证实.
- 大动脉置换 (AVR) 是一个常见的程序,准确的结果评估至关重要.
研究的目的:
- 评估索赔算法的准确性,以评估AVR接受MA患者的并发症和结果.
- 为了比较这些算法在MA与FFS群体中的性能.
- 确定是否可以可靠地使用在批准后的研究中对临床结果的评估.
主要方法:
- 我们比较了来自Evolut低风险试验 (2016-2018) 的MA和FFS患者的11个基于索赔的共变量和结果.
- 使用判定结果作为参考标准.
- 计算了灵敏度,特异性,正预测值,负预测值和kappa协议,比较MA与FFS,使用2个样本z测试 (P<0.05).
主要成果:
- 索赔算法在MA和FFS组中显示出对关键共变量 (糖尿病,高血压,心房/心肌) 和结果 (出血,心脏起器植入,死亡) 的高灵敏度 (≥85%).
- 对于大多数共变量和结果,MA和FFS之间的Kappa协议是相似的.
- 在糖尿病 (P=0.03) 和高血压 (P=0.025) 的MA中观察到更高的卡帕协议,但在心肌梗塞 (P<0.0001) 中较低.
结论:
- 医疗保险索赔数据显示,MA和FFS群体之间的大多数共变量和结果之间具有可比的kappa协议.
- 在批准后的研究中,Medicare索赔用于结果确定仍然适用于某些结果,即使患者入学转向MA计划.
- 这项研究支持在不断变化的医疗保险环境中继续使用索赔数据进行研究.
更多相关视频
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation IV: Nursing Management
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...


